Bitte warten ...
 
Login

KILT -> A Randomized Non Comparative Phase II Study of Lacutamab With GemOx Versus GemOx Alone in Relapsed/Refractory Patients With Peripheral T-cell Lymphoma

EU Clinical Trials Register

Leiter: Herr Prof. Dr. med. Gerald Wulf

 

Herr Prof. Dr. med. Gerald Wulf

Universitätsmedizin Göttingen

E-Mail senden

Informationen zur Studie

Beschreibung

A Randomized Non Comparative Phase II Study of Lacutamab With GemOx Versus GemOx Alone in Relapsed/Refractory Patients With Peripheral T-cell Lymphoma

Zusätzliche Dokumente

Beteiligte Arbeitsgruppen

T-Zell Lymphome (T-NHL)